Combining Clinical, Pathology, and Gene Expression Data to Predict Recurrence of Hepatocellular Carcinoma

肝细胞癌 医学 危险系数 比例危险模型 基因签名 癌症 病理 生存分析 肝癌 肿瘤科 内科学 基因表达 癌症研究 基因 生物 置信区间 生物化学
作者
Augusto Villanueva,Yujin Hoshida,Carlo Battiston,Victoria Tovar,Daniela Sia,Clara Alsinet,Helena Cornellà,Arthur Liberzon,Masahiro Kobayashi,Hiromitsu Kumada,Swan N. Thung,Jordi Bruix,Philippa Newell,Craig April,Jian‐Bing Fan,Sasan Roayaie,Vincenzo Mazzaferro,Myron Schwartz,Josep M. Llovet
出处
期刊:Gastroenterology [Elsevier BV]
卷期号:140 (5): 1501-1512.e2 被引量:398
标识
DOI:10.1053/j.gastro.2011.02.006
摘要

Background & AimsIn approximately 70% of patients with hepatocellular carcinoma (HCC) treated by resection or ablation, disease recurs within 5 years. Although gene expression signatures have been associated with outcome, there is no method to predict recurrence based on combined clinical, pathology, and genomic data (from tumor and cirrhotic tissue). We evaluated gene expression signatures associated with outcome in a large cohort of patients with early stage (Barcelona–Clinic Liver Cancer 0/A), single-nodule HCC and heterogeneity of signatures within tumor tissues.MethodsWe assessed 287 HCC patients undergoing resection and tested genome-wide expression platforms using tumor (n = 287) and adjacent nontumor, cirrhotic tissue (n = 226). We evaluated gene expression signatures with reported prognostic ability generated from tumor or cirrhotic tissue in 18 and 4 reports, respectively. In 15 additional patients, we profiled samples from the center and periphery of the tumor, to determine stability of signatures. Data analysis included Cox modeling and random survival forests to identify independent predictors of tumor recurrence.ResultsGene expression signatures that were associated with aggressive HCC were clustered, as well as those associated with tumors of progenitor cell origin and those from nontumor, adjacent, cirrhotic tissues. On multivariate analysis, the tumor-associated signature G3-proliferation (hazard ratio [HR], 1.75; P = .003) and an adjacent poor-survival signature (HR, 1.74; P = .004) were independent predictors of HCC recurrence, along with satellites (HR, 1.66; P = .04). Samples from different sites in the same tumor nodule were reproducibly classified.ConclusionsWe developed a composite prognostic model for HCC recurrence, based on gene expression patterns in tumor and adjacent tissues. These signatures predict early and overall recurrence in patients with HCC, and complement findings from clinical and pathology analyses. In approximately 70% of patients with hepatocellular carcinoma (HCC) treated by resection or ablation, disease recurs within 5 years. Although gene expression signatures have been associated with outcome, there is no method to predict recurrence based on combined clinical, pathology, and genomic data (from tumor and cirrhotic tissue). We evaluated gene expression signatures associated with outcome in a large cohort of patients with early stage (Barcelona–Clinic Liver Cancer 0/A), single-nodule HCC and heterogeneity of signatures within tumor tissues. We assessed 287 HCC patients undergoing resection and tested genome-wide expression platforms using tumor (n = 287) and adjacent nontumor, cirrhotic tissue (n = 226). We evaluated gene expression signatures with reported prognostic ability generated from tumor or cirrhotic tissue in 18 and 4 reports, respectively. In 15 additional patients, we profiled samples from the center and periphery of the tumor, to determine stability of signatures. Data analysis included Cox modeling and random survival forests to identify independent predictors of tumor recurrence. Gene expression signatures that were associated with aggressive HCC were clustered, as well as those associated with tumors of progenitor cell origin and those from nontumor, adjacent, cirrhotic tissues. On multivariate analysis, the tumor-associated signature G3-proliferation (hazard ratio [HR], 1.75; P = .003) and an adjacent poor-survival signature (HR, 1.74; P = .004) were independent predictors of HCC recurrence, along with satellites (HR, 1.66; P = .04). Samples from different sites in the same tumor nodule were reproducibly classified. We developed a composite prognostic model for HCC recurrence, based on gene expression patterns in tumor and adjacent tissues. These signatures predict early and overall recurrence in patients with HCC, and complement findings from clinical and pathology analyses.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wuyi完成签到,获得积分10
刚刚
雨品完成签到,获得积分10
刚刚
123321完成签到,获得积分10
刚刚
Bonlin完成签到,获得积分10
2秒前
doomedQL完成签到,获得积分10
3秒前
燕子完成签到 ,获得积分10
3秒前
3秒前
啦啦啦完成签到,获得积分10
3秒前
小白完成签到,获得积分10
4秒前
吴秋阳完成签到 ,获得积分10
4秒前
王老师完成签到 ,获得积分10
4秒前
skycool完成签到,获得积分10
5秒前
lujianqi发布了新的文献求助150
6秒前
晓风完成签到,获得积分0
7秒前
congyang完成签到,获得积分20
7秒前
淇淇完成签到 ,获得积分10
8秒前
平常的朝雪完成签到 ,获得积分10
8秒前
bigger.b完成签到,获得积分0
8秒前
lolo完成签到,获得积分10
8秒前
FR完成签到,获得积分10
8秒前
小芒果发布了新的文献求助10
8秒前
kobe完成签到 ,获得积分10
8秒前
5999完成签到 ,获得积分10
9秒前
6666666完成签到,获得积分10
9秒前
3475完成签到,获得积分10
9秒前
Firsterchao的应助被科研通管家采纳,获得10
9秒前
cdercder的应助被科研通管家采纳,获得10
9秒前
Hello的应助被科研通管家采纳,获得10
9秒前
吃人陈完成签到,获得积分10
9秒前
鱼鱼完成签到,获得积分10
9秒前
小二郎的应助被科研通管家采纳,获得10
9秒前
落寞万仇完成签到,获得积分10
9秒前
乐乐笑语的应助被科研通管家采纳,获得10
9秒前
小黑马完成签到,获得积分10
9秒前
桐桐的应助被科研通管家采纳,获得10
10秒前
粼望步完成签到,获得积分10
10秒前
10秒前
cdercder的应助被科研通管家采纳,获得10
10秒前
秒速五厘米完成签到,获得积分0
12秒前
称心小松鼠完成签到,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180111
求助须知:如何正确求助?哪些是违规求助? 9570235
关于积分的说明 21809184
捐赠科研通 7776198
什么是DOI,文献DOI怎么找? 3433262
关于科研通互助平台的介绍 2557463
邀请新用户注册赠送积分活动 2479039